Ovarian cancer historical perspective: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 9: | Line 9: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* In the 16th and 17th centuries, Dr. Lusitani and Dr. Tulp from Holand, believed that [[cancers]] are [[contagious]] after they noticed the presence of [[Breast cancer|breast cancers]] in the same household members | * In the 16th and 17th centuries, Dr. Lusitani and Dr. Tulp from Holand, believed that [[cancers]] are [[contagious]] after they noticed the presence of [[Breast cancer|breast cancers]] in the same household members.<ref name="pmid19103723">{{cite journal| author=Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L et al.| title=Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. | journal=J Clin Oncol | year= 2009 | volume= 27 | issue= 5 | pages= 812-26 | pmid=19103723 | doi=10.1200/JCO.2008.21.2134 | pmc=2645086 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19103723 }} </ref><ref name="pmid8712676">{{cite journal| author=Diamandopoulos GT| title=Cancer: an historical perspective. | journal=Anticancer Res | year= 1996 | volume= 16 | issue= 4A | pages= 1595-602 | pmid=8712676 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8712676 }} </ref><ref name="pmid20960499">{{cite journal| author=Hajdu SI| title=A note from history: landmarks in history of cancer, part 1. | journal=Cancer | year= 2011 | volume= 117 | issue= 5 | pages= 1097-102 | pmid=20960499 | doi=10.1002/cncr.25553 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20960499 }} </ref> | ||
* In 1990, Dr. Mary-Claire King, the professor of [[genome]] sciences from Chicago, was the first one to link the single [[gene]] on [[chromosome 17]] to many [[breast]] and [[Ovarian cancer|ovarian cancers]], after many years of research to find evidence that there is a genetic pattern linked to the incidence of complex [[Disease|diseases]]. | |||
* In 1991, King named the [[gene]] that is linked to many [[breast]] and [[ovarian cancer]]<nowiki/>s as [[BRCA1]].<ref name="ApostolouFostira2013">{{cite journal|last1=Apostolou|first1=Paraskevi|last2=Fostira|first2=Florentia|title=Hereditary Breast Cancer: The Era of New Susceptibility Genes|journal=BioMed Research International|volume=2013|year=2013|pages=1–11|issn=2314-6133|doi=10.1155/2013/747318}}</ref> | |||
* In 1994, King also found and named the second [[gene]], [[BRCA2]] on [[chromosome 13]].<ref name="GodetM. Gilkes2017">{{cite journal|last1=Godet|first1=Inês|last2=M. Gilkes|first2=Daniele|title=BRCA1 and BRCA2 mutations and treatment strategies for breast cancer|journal=Integrative Cancer Science and Therapeutics|volume=4|issue=1|year=2017|issn=20564546|doi=10.15761/ICST.1000228}}</ref> | |||
* 1996, King and the [[Breast Cancer]] [[research]] foundation, conducted a study on women of Ashkenazi Jewish ancestry in NYC and also on Palestinian women, which lead to the definitive confirmation that [[mutations]] in [[BRCA1]] and [[BRCA2]] is linked to the [[incidence]] of [[ovarian]] and [[breast cancer]]. | |||
* | * | ||
Latest revision as of 14:12, 4 September 2019
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer historical perspective On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer historical perspective |
|
Risk calculators and risk factors for Ovarian cancer historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Ovarian cancer was first linked to gene mutations by Dr. King who found and named BRCA1 gene on chromosome 17 in 1990 and BRCA2 gene on chromosome 13 in 1994.
Historical Perspective
- In the 16th and 17th centuries, Dr. Lusitani and Dr. Tulp from Holand, believed that cancers are contagious after they noticed the presence of breast cancers in the same household members.[1][2][3]
- In 1990, Dr. Mary-Claire King, the professor of genome sciences from Chicago, was the first one to link the single gene on chromosome 17 to many breast and ovarian cancers, after many years of research to find evidence that there is a genetic pattern linked to the incidence of complex diseases.
- In 1991, King named the gene that is linked to many breast and ovarian cancers as BRCA1.[4]
- In 1994, King also found and named the second gene, BRCA2 on chromosome 13.[5]
- 1996, King and the Breast Cancer research foundation, conducted a study on women of Ashkenazi Jewish ancestry in NYC and also on Palestinian women, which lead to the definitive confirmation that mutations in BRCA1 and BRCA2 is linked to the incidence of ovarian and breast cancer.
References
- ↑ Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L; et al. (2009). "Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology". J Clin Oncol. 27 (5): 812–26. doi:10.1200/JCO.2008.21.2134. PMC 2645086. PMID 19103723.
- ↑ Diamandopoulos GT (1996). "Cancer: an historical perspective". Anticancer Res. 16 (4A): 1595–602. PMID 8712676.
- ↑ Hajdu SI (2011). "A note from history: landmarks in history of cancer, part 1". Cancer. 117 (5): 1097–102. doi:10.1002/cncr.25553. PMID 20960499.
- ↑ Apostolou, Paraskevi; Fostira, Florentia (2013). "Hereditary Breast Cancer: The Era of New Susceptibility Genes". BioMed Research International. 2013: 1–11. doi:10.1155/2013/747318. ISSN 2314-6133.
- ↑ Godet, Inês; M. Gilkes, Daniele (2017). "BRCA1 and BRCA2 mutations and treatment strategies for breast cancer". Integrative Cancer Science and Therapeutics. 4 (1). doi:10.15761/ICST.1000228. ISSN 2056-4546.